type

Read news on type with our app.

Read more in the app

Type 2 diabetes may suppress reward - EurekAlert

The emerging role of flavonoids in the treatment of type 2 diabetes mellitus: regulating the enteroendocrine system - EurekAlert

Evaluation of inhaled technosphere insulin plus insulin degludec for adults with type 1 diabetes - EurekAlert

Cardiovascular and renal biomarkers in overweight and obese adults with type 1 diabetes treated with tirzepatide - EurekAlert

Plant-based diets considerably enhance glycemic management, cardiovascular health indicators, inflammatory markers, and quality of life for those with type 2 diabetes, randomized controlled trial finds

Minimal TV viewing may be protective for heart diseases linked to Type 2 diabetes - EurekAlert

Scientists create a type of catalog, the ‘colocatome,’ of non-cancerous cells’ influence on cancer - EurekAlert

Scientists create a type of catalog, the 'colocatome,' of non-cancerous cells' influence on cancer

New Study: This Broccoli Compound Could Reduce Your Risk of Type 2 Diabetes

Decoding bone health: Single-cell insights into type 2 diabetes - EurekAlert

Islet transplantation with blood vessel cells shows promise to treat type 1 diabetes

Type 1 diabetes: Hybrid closed-loop and open-loop systems compared

Yo-yo dieting may significantly increase kidney disease risk in people with type 1 diabetes

A Type of Fiber Could Have Weight Loss Benefits Similar to Ozempic

AI-powered blood test spots earliest breast cancer signs: « A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer. »

A Third Type of Magnetism? Altermagnetism Named Top Physics Breakthrough of 2024

Study highlights general practitioner strategies to ease type 2 diabetes management burden - EurekAlert

Insurance coverage, type of employment shape inequities in access to semaglutide - EurekAlert

According to Scientists, This Type of Fat Could Help You Lose Weight and Live Longer

Gene-edited cells that evade rejection show promise in type 1 diabetes